Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)

Maravai Lifesciences Holdings (MRVI) posted quarterly Dividends Paid - Common of -$78000.0 for Q4 2024, down 113.64% quarter-over-quarter from $572000.0 in Q2 2024.

Analysis

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024) Analysis & Trends

Maravai Lifesciences Holdings' Dividends Paid - Common history runs 5 years deep, the most recent figure standing at -$78000.0 for Q4 2024.

  • In Q4 2024, Dividends Paid - Common changed N/A year-over-year to -$78000.0; the TTM figure through Sep 2025 stood at $494000.0 (down 13.64% YoY), while the FY2024 annual figure was $494000.0, down 94.86% from the prior year.
  • Dividends Paid - Common for Q4 2024 stood at -$78000.0, down from $572000.0 in the prior quarter.
  • The five-year high for Dividends Paid - Common was $119.7 million in Q4 2020, with the low at -$78000.0 in Q4 2024.
  • The 5-year median for Dividends Paid - Common is $30.9 million (2022), against an average of $33.1 million.
  • The sharpest annual moves came in 2021 and 2023: Dividends Paid - Common soared 40961.48% in 2021, then plunged 96.94% in 2023.
  • Maravai Lifesciences Holdings' Dividends Paid - Common stood at $119.7 million in 2020, then declined by 8.1% to $110.0 million in 2021, then plunged by 71.89% to $30.9 million in 2022, then slumped by 95.78% to $1.3 million in 2023, then slumped by 105.98% to -$78000.0 in 2024.
  • Business Quant data shows MRVI's Dividends Paid - Common at -$78000.0 in Q4 2024, $572000.0 in Q2 2024, and $1.3 million in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 96.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 34.60 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Maravai Lifesciences Holdings 1.09 Bn 1.02 Bn 20.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -78,000.00
Jun 30, 2024 572,000.00
Jun 30, 2023 1.31 Mn
Mar 31, 2023 8.30 Mn
Dec 31, 2022 30.92 Mn
Sep 30, 2022 36.81 Mn
Jun 30, 2022 42.59 Mn
Mar 31, 2022 39.89 Mn
Dec 31, 2021 110.00 Mn
Sep 30, 2021 50.10 Mn
Jun 30, 2021 33.08 Mn
Mar 31, 2021 23.13 Mn
Dec 31, 2020 119.69 Mn
Sep 30, 2020 122,000.00
Jun 30, 2020 190,000.00